Obesity jabs: Help needed to keep weight off after stopping them
In England alone, obesity affects around one in four adults.An estimated 1.5 million people are on weight loss jabs in the UK, but the vast majority are paying for them privately so will not be eligible for NHS support as they come off the treatment.Wegovy (semaglutide) is already available on the NHS on prescription, but only to those most in need (with health problems due to their weight and a high BMI) for a period of two years.Around 240,000 people are expected to be offered Mounjaro (tirzepatide) over the next three years. There's currently no specified time limit for being prescribed the drug.Both drugs help reduce appetite and can lead to life-changing weight loss. They are prescribed alongside programmes that support healthy weight loss through changes to diet and physical activity.In a Wegovy drug trial, patients regained around two-thirds of their original weight once they came off the injections. It's a similar story for those on Mounjaro.New advice from NICE, the National Institute for Health and Care Excellence, encourages patients to build long-term behavioural habits, use self-monitoring tools, and draw on wider support "from online communities to family-led interventions and local activities."Prof Jonathan Benger from NICE said: "Successful weight management doesn't end when medication stops or when someone completes a behavioural programme."We know that the transition period after treatment is crucial, and people need structured support to maintain the positive changes they've made."Prof Kamila Hawthorn from the Royal College of GPs said: "There is no one-size fits all approach to tackling obesity - what works for one patient will likely not work for another."We also need to see a greater focus on prevention, stopping people becoming overweight in the first place so they don't require a medical intervention later."Obesity can cause people difficulties in their daily lives, and put them at more risk of serious health problems, such as heart disease, type 2 diabetes, and some types of cancer.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
8 minutes ago
- Daily Mail
Health officials tell UK to brace for surge of virus that is the leading cause of death in newborns
Britons have been warned to brace themselves for an upsurge in cases of a deadly lung infection amid a global rise. Respiratory syncytial virus (RSV), which can be deadly for young children and the elderly, flares up every autumn in the UK—just like the flu. But official surveillance data shows Australia has already logged a record number of cases this year. NHS chiefs believe the Australian winter is a good predictor of how viruses will spread in the UK. Spread by coughs and sneezes, it hospitalises around 30,000 children and 18,000 adults in the UK every year, due to serious breathing complications like pneumonia and lung infections. It said that the virus is a leading cause of death among babies. Around 20 to 30 children die from the virus each winter. It's also estimated to contribute to the deaths of 8,000 adults over the same period, due to the increased strain the infection puts on patient's hearts, causing the organ to fail. Officials have now urged pregnant women and those eligible to get the RSV vaccine. Kate Brintworth, chief midwifery officer for NHS England, said: 'While for most adults RSV only causes mild, cold-like symptoms, for older adults and young children it can lead to serious breathing problems that can end up in hospitalisation. 'Getting vaccinated while pregnant is the best way to protect your baby from the moment they are born. 'Now is the time for mums to act, to make sure their babies are protected ahead of their first few months this winter, when there tends to be more bugs circulating.' Last week, data published by the UK Health Security Agency (UKHSA) also showed the jab for pregnant women can prevent almost three quarters (72 per cent) of hospital admissions for their babies. The antibodies the mums produce in response to the jab are passed to their babies in the womb, protecting them for the first six months after being born. Meanwhile, the vaccine is 82 per cent effective at preventing hospital admissions for RSV among older adults, the UKHSA noted. Pregnant women can get the jab from 28 weeks of pregnancy onwards through their maternity services or GP surgery. Older adults aged 75-79 are also eligible for the jab and NHS England will start inviting people to come forward in the next few weeks. The NHS's jab rollout comes as part of its winter vaccine plans, which also includes Covid and flu vaccines. The lung condition spreads by large droplets and the virus can survive on surfaces for up to seven hours. Children remain infectious for up to three weeks, even after their symptoms have passed. Higher risk babies can receive the nirsevimab vaccine from September—with the single jab replacing five monthly injections previously given to infants classed as being at high risk.
Daily Mail
8 minutes ago
- Daily Mail
I've been a personal trainer for 25 years - I avoid this 'healthy' food because it makes you look old
Demand for plant-based meat alternatives, gluten-free snacks and other 'healthy' options has undeniably taken the world by storm. Fuelled by a deluge of alarming reports into the dangers of eating too much processed meat, gluten and refined carbohydrates, supermarket shelves are now packed with 'plant based meat' and grain and nut-packed granolas. But, Tracy Campoli, a certified holistic health coach, warned these so-called "healthy" products could be ageing the body from the inside out, causing chronic inflammation and visible signs of ageing. According to Ms Campoli, some of the most popular plant-based meat-alternatives are seriously lacking in vital nutrients like protein, and are instead packed full of additives, seed oils and salt. In a video posted to YouTube, the fitness coach analysed five different "healthy foods" that are by their very nature highly processed, and concluded that fake meat is one of the worst offenders when it comes to health. 'Just because it's plant-based, it doesn't mean it's healthy—you've got to read your labels,' she warned her 347,000 subscribers. Around 12 per cent of people in the UK eat a meat-free diet, with many choosing to give up red meat in particular because of its supposed link with heart disease and even cancer. But, Ms Campoli warned: 'Some of these so-called "good for you" choices may secretly be sabotaging your skin and even speeding up visible signs of ageing like wrinkles. 'But more plant-based alternatives might actually be causing some fine wrinkles on your face. Ms Campoli continued: 'So many of those mass-marketed plant-based meat alternatives—such as Beyond Meat and Impossible Burger—all use inflammatory oils which can speed up your cellular ageing.' Seed oils such a canola oil, sunflower and rapeseed oils are high in polyunsaturated fats which, it has long been claimed, are a 'heart healthy' substitute for traditional animal fats. But in recent years, they've also found themselves at the centre of a raging health debate. Detractors refer to seed oils as 'The Hateful Eight' – which also include corn, soybean, cottonseed, grapeseed, safflower and rice bran oil. Critics say these oils—which today make up more than 25 per cent of the calories in our diets—are causing obesity and leading to a host of health problems from type 2 diabetes to depression and even migraines. It's a claim that goes against medical advice of the past few decades: butter, dripping and lard are high in 'bad' saturated fats which raise cholesterol and heart disease risk, while seed oils contain unsaturated fats that can decrease cholesterol levels and protect the heart. But according to Ms Campoli seed oils aren't always the healthier option. 'They may sound healthy, but they are actually really not great for our body, causing more oxidative stress,' she warned in the clip. The main concern us that they are high in omega-6 fatty acids, she explained. 'When we have an excess of omega-6 in our body it creates more oxidative stress, damages your skin cells and it can cause wrinkles.' She added that these alternative products are often packed with higher levels of salt than their animal-derived counterparts, as manufacturers try to mimic the taste and texture of real meat. This, she says, can cause people to bloat and make the skin look more puffy. Eating too much salt can also lead to high blood pressure, increasing the risk of heart attack and stroke. 'It's also not good for your skin because sodium can also lead to dehydration,' Ms Campoli added. 'But it's hydration from the inside out gives us that glowy more youthful-looking skin. 'If you're eating a lot of excess salt, you're going to look dry and dehydrated. She concluded: 'All of these ingredients together can cause inflammation in the body. 'Inflammation is the root cause of so many diseases and health problems so we want to do our best to keep inflammation at bay. 'You're better off eating more whole foods than looking for substitutes.' Wholegrain breads that are full of hidden sugars and emulsifiers, granola, rice cakes and gluten-free snack products also made her blacklist. 'Many of these products breads contain hidden sugars which contribute to glycation—meaning it stiffens and weakens your collagen, making your skin saggy and contributing to the visible signs of ageing.' It comes as new research suggests consuming a diet low in ultra-processed foods could help supercharge weight loss. Additive-laden foods have been vilified for decades over their supposed health risks, with dozens of studies linking them to type 2 diabetes, heart disease and even cancer. Now, British scientists who tracked dozens of adults have discovered those who ate a diet rich in minimally processed foods and avoided UPFs, lost twice as much weight as those who often consumed UPFs. Sticking to meals cooked from scratch could also help curb food cravings, they also found. However, diets high in UPFs had little impact on blood pressure, heart rate, liver function and cholesterol. Researchers argued their findings echoed calls to limit certain types of UPFs but cautioned it also showed that not all UPFs are 'inherently unhealthy'.
Sky News
19 minutes ago
- Sky News
Ozempic to Mounjaro - what are the weight loss injections and what were they designed to do?
Drugs designed to treat diabetes and repurposed as miracle diet aids have taken over TikTok - and Hollywood. The weight loss caused by these weekly injectables is rapid and previously unattainable, people boast, showing off newly svelte bodies. But what are these drugs, how do they work - and what were they originally designed to do? Ozempic, Wegovy, Mounjaro - what are they? Let's start with the most well-known of the trio: Ozempic. Ozempic blew up in 2022 - if media reports from the US were to be believed, every pound dropped in LA was probably thanks to the "miracle" injectable drug. What started as the preserve of A-listers and the Hollywood elite quickly grew in popularity. The drug's generic name is semaglutide. This is the same as Wegovy, which has been licensed as a weight loss drug in the UK and is now available on the NHS. Wegovy has a slightly higher dosage and is designed for weight loss, while Ozempic's primary purpose was as a diabetes treatment (more on that later). Mounjaro - also known by its generic name tirzepatide - is the newer kid on the block. Like Ozempic and Wegovy, it suppresses the appetite and lengthens the amount of time food stays in the stomach, leading to weight loss - at least for as long as you carry on taking it. In 2022, the US Food and Drink Administration (FDA) fast-tracked approval of the drug to treat obesity after a study showed it helped people lose more than 20% of their bodyweight. Mounjaro was supposed to be available through GP surgeries and other community services in the UK from 23 June. But at the start of August, Sky News research revealed only eight of 42 NHS Integrated Care Boards (ICBs) in England had started providing treatment to patients, and many of the rest unable to guarantee when it would be available. 3:31 From diabetes drug to diet pill Ozempic and Mounjaro were both developed as treatments for type 2 diabetes. The drugs, which come as weekly injections, lower blood sugar by increasing insulin production when your blood sugar is rising and helping prevent your liver making and releasing too much sugar. So how do they cause weight loss? Both semaglutide and tirzepatide work by mimicking the hormone, GLP-1 (glucagon-like peptide one), to manage hunger and slow down digestion. Tirzepatide - Mounjaro - is a dual-acting drug and also mimics the hormone GIP (glucose-dependent insulinotropic polypeptide). In terms of weight loss, in clinical trials people lost up to 20% of their body weight on tirzepatide and 15% on semaglutide. Researchers have also found the weight loss jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose. They sound like miracle drugs for people wanting to lose weight - what's the catch? There are a few downsides. First off, the listed side effects: nausea, vomiting and diarrhoea, bad enough for about 5% of people in the semaglutide trial to stop taking it and 6-7% in the tirzepatide trial. People in the semaglutide trial also experienced problems with gallstones. The drugs also carry serious risks including kidney failure, pancreatitis and thyroid cancer. Another downside has been dubbed "Ozempic face". Facial ageing is a side effect of sudden weight loss as people find the skin on their face sagging where once it was plump. The drugs also only work for as long as you carry on taking them, and people have reported gaining back all the weight they lost after stopping the drug - either out of choice or because of a supply shortage. In August, the National Institute for Health and Care Excellence (NICE) - the body that provides guidance on the use of new drugs - said that people coming off the drugs should be offered "structured advice and follow-up support" to help prevent weight gain. This includes being monitored by the NHS for at least a year after completing treatment and support to help build "long-term behavioural habits, use self-monitoring tools, and draw on wider support - from online communities to family-led interventions and local activities". Shortages for diabetics Perhaps a bigger conversation than side effects for individuals is around the impact on people who rely on these treatments, now they've exploded in popularity as a weight loss quick-fix. While intended for diabetics, Ozempic and Mounjaro are prescribed "off-label" in the US to people wanting to shed weight. The drugs faced widespread shortage last year, with reports of diabetics having to drive from pharmacy to pharmacy in search of stock because of the high demand. Links to cancer prevention Research has suggested weight loss jabs, officially GLP-1 receptor agonists, could almost halve the risk of obesity-related cancers. The study, published in the journal eClinicalMedicine, was presented at the European Congress on Obesity in Malaga. It found that there were similar rates of obesity -related cancer among patients treated with the injections and those given weight loss, or bariatric, surgery. Dr Yael Wolff Sagy, the study's co-lead author from Clalit Health Services in Tel-Aviv, Israel, said a "direct effect" of the injections was that they were found "to be 41% more effective at preventing obesity-related cancer". "We do not yet fully understand how GLP-1s work," she said. "But this study adds to the growing evidence showing that weight loss alone cannot completely account for the metabolic, anti-cancer, and many other benefits that these medications provide." Co-lead Professor Dror Dicker, from Hasharon Hospital, Rabin Medical Centre in Israel, suggested the protective effects of the drugs "likely arise from multiple mechanisms, including reducing inflammation". He added further research was needed "to make sure that these drugs do not increase the risk for non-obesity-related cancers". Being overweight or obese is the second biggest cause of cancer in the UK, causing more than one in 20 cancer cases, according to the NHS. Are they available in the UK? An estimated 1.5 million people are taking weight loss jabs in the UK, the vast majority of whom pay for them privately. Ozempic is available in the UK for type 2 diabetes patients with a prescription. Wegovy and Mounjaro is available to NHS patients, but only through specialist weight management services. Over the next three years, around 240,000 people with the "greatest need" are expected to receive Mounjaro through the NHS. However, Sky News research into Wegovy and Mounjaro shows delays in the rollout of both weight loss jabs.
